XML 145 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible assets - Additional Information (Detail)
$ in Thousands, $ in Thousands
12 Months Ended
Mar. 06, 2017
Nov. 30, 2023
USD ($)
Nov. 30, 2023
CAD ($)
Nov. 30, 2022
USD ($)
Nov. 30, 2021
USD ($)
Nov. 30, 2019
USD ($)
shares
Nov. 30, 2019
CAD ($)
Nov. 30, 2017
USD ($)
Nov. 30, 2016
USD ($)
Nov. 30, 2023
CAD ($)
Nov. 30, 2022
CAD ($)
May 31, 2022
USD ($)
Nov. 30, 2021
CAD ($)
Mar. 31, 2021
shares
May 15, 2018
shares
Dec. 01, 2017
USD ($)
Dec. 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
Disclosure of detailed information about intangible assets [line items]                                    
Amortisation Expense   $ 2,513   $ 9,211 $ 3,180                          
Net sales   81,764   80,057 69,823                          
Additions to intangibles Through cash payment   1,000                                
Intangible assets   12,496   15,009                            
Trogarzo®                                    
Disclosure of detailed information about intangible assets [line items]                                    
Intangible assets                       $ 6,356            
Europe [Member]                                    
Disclosure of detailed information about intangible assets [line items]                                    
Net sales   286   1,261 1,455                          
Katana                                    
Disclosure of detailed information about intangible assets [line items]                                    
Number of shares issued | shares                           120,482        
Acquisition of intangible assets during the year   3,073                                
Business combination cash consideration transferred   1,965                                
Business combination shares value of consideration           $ 5                        
Business combination number of shares issued | shares           900                        
Business combination acquisition costs   75                                
Business combination contingent consideration fair value   1,028                                
Number of shares issued and fully paid | shares                           120,482        
Katana Amendment Agreement                                    
Disclosure of detailed information about intangible assets [line items]                                    
Business combination contingent consideration                   $ 2,300                
Acquisition of intangible assets during the year           $ 376 $ 500                      
Business combination adjustment to the purchase consideration             1,080                      
Subsidy or grants received             $ 1,200                      
Regulatory payable milestone related                   200                
Katana Amendment Agreement | Business Combination Adjustment To Consideration Installment One                                    
Disclosure of detailed information about intangible assets [line items]                                    
Business combination cash consideration transferred                   $ 500                
Katana Amendment Agreement | Business Combination Adjustment To Consideration Installment Two                                    
Disclosure of detailed information about intangible assets [line items]                                    
Business combination contingent consideration   $ 580                                
Katana Amendment Agreement | Royalty Related License Peptides | First Five Years                                    
Disclosure of detailed information about intangible assets [line items]                                    
Annual maintenance fees     $ 25                              
Katana Amendment Agreement | Royalty Related License Peptides | After Five Years                                    
Disclosure of detailed information about intangible assets [line items]                                    
Annual maintenance fees     $ 100                              
Katana Amendment Agreement | Development Milestone Phase One Clinical Trial                                    
Disclosure of detailed information about intangible assets [line items]                                    
Milestone amount payable         39               $ 50          
Katana Amendment Agreement | Development Milestone Phase Two Clinical Trial                                    
Disclosure of detailed information about intangible assets [line items]                                    
Milestone amount payable                         100          
Katana Amendment Agreement | Development Milestone Phase Three Clinical Trial                                    
Disclosure of detailed information about intangible assets [line items]                                    
Milestone amount payable                         $ 200          
Katana Amendment Agreement | Top of range | Net Sales Basis                                    
Disclosure of detailed information about intangible assets [line items]                                    
Royalty fees in percentage   2.50% 2.50%                              
Katana Amendment Agreement | Top of range | Royalty Revenue Sublicense Basis                                    
Disclosure of detailed information about intangible assets [line items]                                    
Royalty fees in percentage   15.00% 15.00%                              
Katana Amendment Agreement | Bottom of range | Net Sales Basis                                    
Disclosure of detailed information about intangible assets [line items]                                    
Royalty fees in percentage   1.00% 1.00%                              
Katana Amendment Agreement | Bottom of range | Royalty Revenue Sublicense Basis                                    
Disclosure of detailed information about intangible assets [line items]                                    
Royalty fees in percentage   5.00% 5.00%                              
Taimed Agreement                                    
Disclosure of detailed information about intangible assets [line items]                                    
Upfront payment   $ 3,000                                
First milestone installment       3,500                            
Second milestone installment         3,500                          
Additions to intangibles   2,832             $ 5,207                  
Acquisition costs                 $ 207                  
Net sales         $ 20,000                          
Milestone Payments annual installment                                 $ 1,500  
Additions to intangibles Through cash payment   1,000                                
Additions to intangibles Through share based payment   $ 4,000                                
Initial Milestone Payments Payable Aggregate Annual Installments.       $ 7,000                            
Taimed Agreement | Milestone One                                    
Disclosure of detailed information about intangible assets [line items]                                    
Launch milestone payable                               $ 5,000    
Taimed Agreement | Milestone One | Europe [Member]                                    
Disclosure of detailed information about intangible assets [line items]                                    
Net sales               $ 50,000                    
Taimed Agreement | Ordinary shares                                    
Disclosure of detailed information about intangible assets [line items]                                    
Number of shares issued | shares                             1,463,505      
Taimed Agreement | Commercialization rights- Trogarzo® North American Territory                                    
Disclosure of detailed information about intangible assets [line items]                                    
Intangible Asset Purchase Consideration 52.00%                                  
Initial payments                                   $ 5,000
Taimed Agreement | Commercialization rights- Trogarzo® North American Territory | Ordinary shares                                    
Disclosure of detailed information about intangible assets [line items]                                    
Number of shares issued | shares                             1,463,505      
Taimed Agreement | Commercialization Rights Trogarzo                                    
Disclosure of detailed information about intangible assets [line items]                                    
Intangible Assets Agreement Term 12 years                                  
License Agreement Transfer Plus L P | Katana | Milestone Phase Two Live Demonstration                                    
Disclosure of detailed information about intangible assets [line items]                                    
Business combination contingent consideration                     $ 2,300